STOCK TITAN

Healwell AI A SUB VTG (HWAIF) Stock News, Feb-Mar 2025

HWAIF OTC

HEALWELL AI Inc. develops and commercializes healthcare artificial intelligence software for preventative care, with a focus on clinical decision support, early disease identification, and workflow tools for healthcare providers. News about HWAIF commonly covers the company’s DARWEN™ AI platform, Smart Search, Smart Summary, Smart ID, and the use of AI-enriched clinical data to support real-world evidence across disease areas.

Company updates also include revenue and Adjusted EBITDA reporting, integration of Orion Health, enterprise health-system and Health Information Exchange software contracts, customer renewals, scientific publications, conference participation, and board or governance changes. HEALWELL trades on the Toronto Stock Exchange as AIDX and on the OTCQX market as HWAIF.

Rhea-AI Summary

HEALWELL AI Inc. (TSX: AIDX) reported significant financial results for 2024, with record annual revenue of $39 million, representing a 433% increase from 2023. The company's Q4-2024 revenue reached $15.2 million, up 692% year-over-year.

A major highlight is the pending acquisition of Orion Health, expected to close on April 1, 2025. This acquisition, valued at NZD $175 million plus potential earnout of NZD $25 million, is anticipated to contribute over $100 million in annual revenues and make HEALWELL Adjusted EBITDA positive. The company has secured over $100 million in financing arrangements, including a recently signed $50 million credit agreement with Scotiabank and RBC.

However, HEALWELL reported an increased Adjusted EBITDA loss of $16 million for 2024, compared to $7.9 million in 2023. The company's gross margin improved to 44% in 2024 from 17% in 2023. Cash position stood at $9.4 million as of December 31, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.88%
Tags
-
Rhea-AI Summary

HEALWELL AI Inc. (TSX: AIDX) reported exceptional growth in fiscal 2024, with annual revenue reaching $39 million, a 433% increase from 2023. Q4-2024 revenue hit $15.2 million, up 692% year-over-year.

The company announced a transformational acquisition of Orion Health Holdings , expected to close on April 1, 2025. Orion Health, with over 70 worldwide customers across 11 countries, is projected to contribute more than $100 million in annual revenues and make HEALWELL Adjusted EBITDA positive.

Key financial metrics for 2024 include:

  • Gross Profit of $17.3 million (44% margin)
  • Adjusted EBITDA loss of $1 million
  • Cash position of $9.4 million as of December 31, 2024

To support the Orion acquisition, HEALWELL secured over $100 million in financing, including a $50 million credit agreement with Scotiabank and RBC, plus subscription receipt financings. The total purchase price is NZD 175 million plus a performance-based earnout of up to NZD 25 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.88%
Tags
-
Rhea-AI Summary

HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF), a healthcare artificial intelligence company specializing in preventative care, has scheduled the release of its Fourth Quarter and Year End 2024 financial results on Wednesday, March 26, 2025.

The company will host a conference call and simultaneous webcast to discuss the results for the period ended December 31, 2024, at 1:00 PM ET (10:00 AM PT). The presentation will be led by CEO Dr. Alexander Dobranowski and CFO Anthony Lam.

Participants can join via webcast or phone, with toll-free access available for North American callers at 1-833-752-3509 and international toll at 1-647-846-7993. Attendees are advised to dial in 10 minutes before the call start time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.81%
Tags
Rhea-AI Summary

HEALWELL AI Inc. (TSX: AIDX, OTCQX: HWAIF) has secured a $50 million credit agreement to support its acquisition of Orion Health. The credit facility, led by Scotiabank and RBC, includes a $20 million term loan and a $30 million revolving credit facility, with an additional uncommitted accordion feature of up to $25 million.

Combined with recent subscription receipt financings, HEALWELL has arranged over $100 million in total financing for the Orion Health acquisition. The company has initiated the pre-closing reorganization process by advancing NZD$5 million to the vendor, targeting a closing date of April 1, 2025.

Orion Health is a global Healthcare Intelligence Platform serving approximately 150 million lives across 11 countries. The acquisition will expand HEALWELL's footprint in preventative care and AI-driven healthcare solutions, particularly strengthening its presence in the public sector through Orion's government relationships.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.07%
Tags
-
Rhea-AI Summary

HEALWELL AI (TSX: AIDX, OTCQX: HWAIF), a healthcare AI company specializing in preventative care, has announced its participation in two major upcoming investor conferences.

The company will first attend the 28th Annual Scotiabank TMT Conference on March 4-5, 2025, in Toronto. CEO Dr. Alexander Dobranowski will deliver a presentation on March 5 at 12:25 PM ET and participate in a keynote panel discussion titled 'AI and the Digital Health Ecosystem: Building a Smarter Future.'

Subsequently, HEALWELL will participate in the 37th Annual ROTH Conference from March 16-18, 2025, in Dana Point, California. This event, one of North America's largest small-cap gatherings, will feature approximately 450 companies across various growth sectors. Dr. Dobranowski will conduct one-on-one meetings with investors to discuss HEALWELL's AI-powered healthcare solutions and preventative care vision.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.05%
Tags
conferences
-
Rhea-AI Summary

HEALWELL AI (TSX: AIDX, OTCQX: HWAIF) has announced that its subsidiary VeroSource Solutions has launched new Digital Twin functionality on its VS Data-as-a-Service Platform. The technology creates a virtual representation of healthcare facilities, enabling real-time analysis and prediction without disrupting operations.

The Digital Twin system features seamless data integration of HL7 and ERP data, dynamic virtual modeling for real-time facility visualization, and enhanced decision-making capabilities. It incorporates population demographics, disease trends, and external factors to help healthcare professionals optimize operations, reduce costs, and improve patient care.

VeroSource's platform securely integrates health data from various sources including EMRs, pharmacies, and hospital information systems into a single platform. The infrastructure is fully compatible with HEALWELL's AI capabilities, allowing for expansion of digital co-pilot tools and data visualization across both companies' footprints.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.48%
Tags
none
Rhea-AI Summary

HEALWELL AI's subsidiary Khure Health reported significant growth in Q4-2024, with its AI-Powered Physician Co-Pilots helping identify over 43,000 high-risk patients across 8 clinical specialties using 132 disease-specific algorithms. This represents a 22% quarter-over-quarter growth and 500% year-over-year growth compared to Q4-2023.

The company secured 4 new Master Services Agreements with pharmaceutical partners in Q4-2024, bringing the total to 16 MSAs, including partnerships with 7 of the world's 10 largest pharmaceutical companies. Khure's physician survey revealed an Net Promoter Score (NPS) of 84, with 82% of physicians confirming improved patient care through the AI technology.

HEALWELL has now onboarded over 800 physicians using its Khure Co-Pilots, with the WELL AI Decision Support (WAIDS) Program being the fastest-growing component, representing approximately 80% of new physician onboarding in Q4.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.33%
Tags
AI
-
Rhea-AI Summary

HEALWELL AI's subsidiary Pentavere has published a groundbreaking study in the Journal of Liquid Biopsy, demonstrating the effectiveness of their DARWEN™ AI platform in oncology care. The study, conducted with Princess Margaret Cancer Centre, shows the platform achieves a 100-fold improvement in processing time compared to manual methods when analyzing complex next-generation sequencing and liquid biopsy reports.

The research validates DARWEN™ AI as a leading clinical decision support tool for identifying actionable genomic alterations in lung cancer patients, enabling faster personalized treatment initiation. This is particularly significant as lung cancer is the second most common cancer and leading cause of cancer-related deaths worldwide. The study highlights how liquid biopsies, using blood tests instead of surgical procedures, can accelerate cancer treatment and personalized care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.10%
Tags
AI
-
Rhea-AI Summary

HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) has received approval from New Zealand's Overseas Investment Office (OIO) to acquire Orion Health Holdings for NZD$175 million, with an additional performance-based earnout of up to NZD$25 million. The transaction is expected to close by April 1, 2025.

Orion Health, a global healthcare technology leader, serves over 70 customers across 11 countries with approximately 400 team members. The acquisition will expand HEALWELL's reach to over 150 million covered lives globally and strengthen its position in healthcare AI and preventative care. The company generates revenue through subscription licenses and services, primarily serving public sector clients with data interoperability and healthcare navigation solutions.

The merger aims to leverage synergies between both companies, focusing on AI-driven healthcare innovation and early disease detection. The OIO consent includes standard conditions for overseas acquisitions of New Zealand business assets, with a requirement to complete the acquisition by February 28, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.67%
Tags
Rhea-AI Summary

HEALWELL AI (TSX: AIDX, OTCQX: HWAIF) announced a strategic cost optimization initiative expected to yield at least $3.0 million in annual savings. The restructuring includes headcount reductions, public company costs cuts, and decreased marketing expenses, preparing for the integration of its upcoming Orion Health acquisition.

The company received a $50 million credit facility commitment from a Schedule I Canadian bank for the Orion acquisition, expected to close by April 1, 2025. The acquisition will add approximately 400 employees and 11 global offices. HEALWELL expects minimal impact from potential U.S. tariffs, as it generates most revenues outside the U.S. and plans to expand AI product distribution through Orion's international network.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.20%
Tags
none

FAQ

What is the current stock price of Healwell AI A SUB VTG (HWAIF)?

Healwell AI A SUB VTG (HWAIF) last closed at $0.3924.

What is the market cap of Healwell AI A SUB VTG (HWAIF)?

The market cap of Healwell AI A SUB VTG (HWAIF) is approximately $131.2M.